Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Sep 17 2020

Sep 17, 2020 at 4:29 PM EDT · Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE · Sep 17, 2020 at 4:29 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/press-release-sep-17-2020-4

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23

Release

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 17, 2020, titled "Dr. Reddy's Laboratories announces settlement ofU.S. Revlimid�� (lenalidomide) Capsules patent litigation with Celgene, a Bristol MyersSquibb Company".

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Press Release Sep 16 2020Sep 16, 2020
Press Release Sep 09 2020Sep 9, 2020
Press Release Sep 07 2020Sep 7, 2020
Press Release Sep 03 2020Sep 3, 2020
Press Release Aug 27 2020Aug 27, 2020

Later from Dr. Reddy's Laboratories

Press Release Sep 25 2020Sep 25, 2020
Press Release Sep 26 2020Sep 26, 2020
Press Release Oct 01 2020Oct 1, 2020
Press Release Oct 03 2020Oct 3, 2020
Press Release Oct 05 2020Oct 5, 2020

All Dr. Reddy's Laboratories news releases

Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.

Follow Dr. Reddy's Laboratories